# Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets

> **NCT01083290** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Spironolactone
- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT01083290
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2010-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083290, "Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01083290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*